Choksi Laboratories Ltd.
BSE: CHOKSILA · Healthcare Service Provider
Limited coverage
We are not actively covering this company or have limited coverage today. Click to request coverage.
Snapshot
Unlock Choksi Laboratories Ltd.'s vital signs
Growth · Profitability · Valuation · Strength · Conviction
Company Overview
Business
Choksi Laboratories Limited provides comprehensive quality control, analytical testing, and calibration services across diverse sectors including pharmaceuticals, food, and environmental monitoring. Headquartered in Indore, the company operates an accredited laboratory network to ensure regulatory compliance for both domestic and multinational clients.
Business Model
The company generates revenue by providing fee-based testing, inspection, and certification services to industrial clients requiring quality assurance and regulatory adherence. It leverages its NABL-accredited laboratory infrastructure to offer specialized technical consultancy and instrument calibration.
Growth Outlook
Growth is driven by increasing demand for stringent quality control in the pharmaceutical and food sectors, alongside expanding requirements for environmental monitoring. The company aims to leverage its technical expertise to capture a larger share of the Indian testing, inspection, and certification market.
Key Risks
- Regulatory Compliance Risk. Failure to maintain NABL accreditation or meet evolving national and international regulatory standards could severely impact the company's operational license and reputation.
- Intense Market Competition. The testing and certification industry is highly fragmented, leading to significant pricing pressure from both domestic players and large multinational testing firms.
- Technological Obsolescence. The requirement for continuous capital expenditure to upgrade laboratory equipment and analytical technology poses a risk to profit margins.
- Client Concentration. Reliance on a diverse client base, including large multinational corporations, makes the company vulnerable to shifts in the outsourcing strategies of major industrial sectors.
Start your research today
Unlock AI insights, financials, peers and live data on Choksi Laboratories Ltd. and 5,000+ companies — free.
Key Metrics
REVENUE
₹46 Cr
TTM · standalone
NET PROFIT
₹2 Cr
TTM · standalone
EPS
₹2.82
TTM · standalone
RETURN ON EQUITY
8.2%
TTM · standalone
RETURN ON CAPITAL EMPLOYED
13.9%
TTM · standalone
P/E
64.3x
Q4 FY26 · standalone
EV/EBITDA
13.6x
Q4 FY26 · standalone
EBITDA MARGIN
26.8%
TTM · standalone
NET PROFIT MARGIN
8.0%
Q4 FY26 · standalone
DEBT TO EQUITY
1.2x
Q4 FY26 · standalone
Peers · Healthcare Service Provider
| Company | Mkt Cap | P/E | EV/EBITDA | Rev Gr YoY | EBITDA Mgn | ROE | ROCE | 1Y Return |
|---|---|---|---|---|---|---|---|---|
Choksi Laboratories Ltd.CHOKSILA | ₹137 Cr | 64.26 | 13.59 | 10.1% | 26.8% | 8.2% | 13.9% | -1.8% |
Suraksha Diagnostic Ltd.SURAKSHA | ₹1,851 Cr | 50.02 | 17.47 | 22.5% | 32.7% | 15.8% | 18.6% | +17.7% |
Krsnaa Diagnostics Ltd.KRSNAA | ₹1,817 Cr | 18.46 | 8.75 | 10.2% | 32.5% | 10.5% | 13.3% | -28.2% |
3B BlackBio Dx Ltd3BBLACKBIO | ₹1,229 Cr | 25.08 | 14.76 | 54.3% | 52.8% | 19.0% | 24.1% | +18.1% |
One Global Service Provider LimitedONEGLOBAL | ₹1,062 Cr | 13.88 | 10.52 | 161.6% | 19.4% | 69.4% | 92.5% | +93.2% |
Gaudium IVF and Women Health LimitedGAUDIUMIVF | ₹857 Cr | — | — | — | 36.0% | — | — | — |
As of Q4 FY26
Financials
Choksi Laboratories Ltd.
BSE: CHOKSILA · Healthcare Service Provider
Limited coverage
We are not actively covering this company or have limited coverage today. Click to request coverage.
Snapshot
Unlock Choksi Laboratories Ltd.'s vital signs
Growth · Profitability · Valuation · Strength · Conviction
Company Overview
Business
Choksi Laboratories Limited provides comprehensive quality control, analytical testing, and calibration services across diverse sectors including pharmaceuticals, food, and environmental monitoring. Headquartered in Indore, the company operates an accredited laboratory network to ensure regulatory compliance for both domestic and multinational clients.
Business Model
The company generates revenue by providing fee-based testing, inspection, and certification services to industrial clients requiring quality assurance and regulatory adherence. It leverages its NABL-accredited laboratory infrastructure to offer specialized technical consultancy and instrument calibration.
Growth Outlook
Growth is driven by increasing demand for stringent quality control in the pharmaceutical and food sectors, alongside expanding requirements for environmental monitoring. The company aims to leverage its technical expertise to capture a larger share of the Indian testing, inspection, and certification market.
Key Risks
- Regulatory Compliance Risk. Failure to maintain NABL accreditation or meet evolving national and international regulatory standards could severely impact the company's operational license and reputation.
- Intense Market Competition. The testing and certification industry is highly fragmented, leading to significant pricing pressure from both domestic players and large multinational testing firms.
- Technological Obsolescence. The requirement for continuous capital expenditure to upgrade laboratory equipment and analytical technology poses a risk to profit margins.
- Client Concentration. Reliance on a diverse client base, including large multinational corporations, makes the company vulnerable to shifts in the outsourcing strategies of major industrial sectors.
Start your research today
Unlock AI insights, financials, peers and live data on Choksi Laboratories Ltd. and 5,000+ companies — free.
Key Metrics
REVENUE
₹46 Cr
TTM · standalone
NET PROFIT
₹2 Cr
TTM · standalone
EPS
₹2.82
TTM · standalone
RETURN ON EQUITY
8.2%
TTM · standalone
RETURN ON CAPITAL EMPLOYED
13.9%
TTM · standalone
P/E
64.3x
Q4 FY26 · standalone
EV/EBITDA
13.6x
Q4 FY26 · standalone
EBITDA MARGIN
26.8%
TTM · standalone
NET PROFIT MARGIN
8.0%
Q4 FY26 · standalone
DEBT TO EQUITY
1.2x
Q4 FY26 · standalone
Peers · Healthcare Service Provider
As of Q4 FY26